Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis

Ascioglu, SİBEL; Leblebicioglu, Hakan; Vahaboglu, Haluk; Chan, K.

doi:10.1093/jac/dkr136

Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis

Ascioglu S., Leblebicioglu H., Vahaboglu H., Chan K. A.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.66, sa.6, ss.1215-1222, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Derleme
Cilt numarası: 66 Sayı: 6
Basım Tarihi: 2011
Doi Numarası: 10.1093/jac/dkr136
Dergi Adı: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1215-1222
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Hacettepe Üniversitesi Adresli: Evet

Özet

Background: Crimean-Congo haemorrhagic fever (CCHF) is a potentially fatal tick-borne infection. The virus is widely distributed around the world and reports of sporadic cases and outbreaks have recently increased significantly. Some authors have proposed that ribavirin improves survival in CCHF and this view appears to be widely accepted.